Connect with us

Health

Recbio Announces New Study Showing Its COVID-19 Vaccine Induced High Levels of Neutralizing Antibodies against SARS-CoV-2 and Variants of Concern – ACROFAN USA

TAIZHOU, China, Nov. 9, 2021 /PRNewswire/ — Jiangsu Recbio Technology Co., Ltd. (“Recbio”), a biopharmaceutical company focusing…

Published

on

Article feature image

TAIZHOU, China, Nov. 9, 2021 /PRNewswire/ — Jiangsu Recbio Technology Co., Ltd. (“Recbio”), a biopharmaceutical company focusing on the research, development and commercialization of innovative vaccines that can address prevalent diseases with significant…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending